Innovent declares Phase 3 success for ADC that attracted huge Takeda deal

June 5, 2026 11:32 AM EDT R&D In­novent de­clares Phase 3 suc­cess for gas­tric can­cer ADC that at­tract­ed huge Take­da deal Ayisha Sharma News Reporter In­novent Bi­o­log­ics’ ADC can­di­date has passed a Phase 3 tri­al in ad­vanced stom­ach can­cer and is un­der pri­or­i­ty re­view in Chi­na, but de­tails of the … Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox. SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER